TY - JOUR
T1 - Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region
AU - Lee, Jong Min
AU - Gillis, Tammy
AU - Mysore, Jayalakshmi Srinidhi
AU - Ramos, Eliana Marisa
AU - Myers, Richard H.
AU - Hayden, Michael R.
AU - Morrison, Patrick J.
AU - Nance, Martha
AU - Ross, Christopher A.
AU - Margolis, Russell L.
AU - Squitieri, Ferdinando
AU - Griguoli, Annamaria
AU - Di Donato, Stefano
AU - Gomez-Tortosa, Estrella
AU - Ayuso, Carmen
AU - Suchowersky, Oksana
AU - Trent, Ronald J.
AU - McCusker, Elizabeth
AU - Novelletto, Andrea
AU - Frontali, Marina
AU - Jones, Randi
AU - Ashizawa, Tetsuo
AU - Frank, Samuel
AU - Saint-Hilaire, Marie Helene
AU - Hersch, Steven M.
AU - Rosas, Herminia D.
AU - Lucente, Diane
AU - Harrison, Madaline B.
AU - Zanko, Andrea
AU - Abramson, Ruth K.
AU - Marder, Karen
AU - Sequeiros, Jorge
AU - MacDonald, Marcy E.
AU - Gusella, James F.
N1 - Funding Information:
We thank the HD research participants and their families, who made this work possible; the Harvard Brain Tissue Resource Center; the COHORT Study of the Huntington Study Group; and the Myocardial Infarction Genetics Consortium (MIGen) study, which was funded by grants from the U.S. National Institutes of Health and National Heart, Lung, and Blood Institute's STAMPEED genomics research program (R01 HL087676) and the National Center for Research Resources (U54 RR020278). We also thank investigators and contributors to the HD-MAPS study: Alexandra Durr, Adam Rosenblatt, Luigi Frati, Susan Perlman, P. Michael Conneally, Mary Lou Klimek, Melissa Diggin, Tiffany Hadzi, and Ayana Duckett. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS16367) (Huntington's Disease Center Without Walls) and NS32765, the CHDI Foundation, and the Huntington's Disease Society of America's Coalition for the Cure. E.M.R. received a scholarship from the Fundação para a Ciência e a Tecnologia of Portugal (SFRH/BD/44335/2008).
PY - 2012/3/9
Y1 - 2012/3/9
N2 - Age at the onset of motor symptoms in Huntington disease (HD) is determined largely by the length of a CAG repeat expansion in HTT but is also influenced by other genetic factors. We tested whether common genetic variation near the mutation site is associated with differences in the distribution of expanded CAG alleles or age at the onset of motor symptoms. To define disease-associated single-nucleotide polymorphisms (SNPs), we compared 4p16.3 SNPs in HD subjects with population controls in a case:control strategy, which revealed that the strongest signals occurred at a great distance from the HD mutation as a result of "synthetic association" with SNP alleles that are of low frequency in population controls. Detailed analysis delineated a prominent ancestral haplotype that accounted for ∼50% of HD chromosomes and extended to at least 938 kb on about half of these. Together, the seven most abundant haplotypes accounted for ∼83% of HD chromosomes. Neither the extended shared haplotype nor the individual local HTT haplotypes were associated with altered CAG-repeat length distribution or residual age at the onset of motor symptoms, arguing against modification of these disease features by common cis-regulatory elements. Similarly, the 11 most frequent control haplotypes showed no trans-modifier effect on age at the onset of motor symptoms. Our results argue against common local regulatory variation as a factor influencing HD pathogenesis, suggesting that genetic modifiers be sought elsewhere in the genome. They also indicate that genome-wide association analysis with a small number of cases can be effective for regional localization of genetic defects, even when a founder effect accounts for only a fraction of the disorder.
AB - Age at the onset of motor symptoms in Huntington disease (HD) is determined largely by the length of a CAG repeat expansion in HTT but is also influenced by other genetic factors. We tested whether common genetic variation near the mutation site is associated with differences in the distribution of expanded CAG alleles or age at the onset of motor symptoms. To define disease-associated single-nucleotide polymorphisms (SNPs), we compared 4p16.3 SNPs in HD subjects with population controls in a case:control strategy, which revealed that the strongest signals occurred at a great distance from the HD mutation as a result of "synthetic association" with SNP alleles that are of low frequency in population controls. Detailed analysis delineated a prominent ancestral haplotype that accounted for ∼50% of HD chromosomes and extended to at least 938 kb on about half of these. Together, the seven most abundant haplotypes accounted for ∼83% of HD chromosomes. Neither the extended shared haplotype nor the individual local HTT haplotypes were associated with altered CAG-repeat length distribution or residual age at the onset of motor symptoms, arguing against modification of these disease features by common cis-regulatory elements. Similarly, the 11 most frequent control haplotypes showed no trans-modifier effect on age at the onset of motor symptoms. Our results argue against common local regulatory variation as a factor influencing HD pathogenesis, suggesting that genetic modifiers be sought elsewhere in the genome. They also indicate that genome-wide association analysis with a small number of cases can be effective for regional localization of genetic defects, even when a founder effect accounts for only a fraction of the disorder.
UR - http://www.scopus.com/inward/record.url?scp=84862831145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862831145&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2012.01.005
DO - 10.1016/j.ajhg.2012.01.005
M3 - Article
C2 - 22387017
AN - SCOPUS:84862831145
SN - 0002-9297
VL - 90
SP - 434
EP - 444
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
IS - 3
ER -